knowledge -WSS

knowledge

author：focus 2025-10-01 04:13:41 - browse：8521

Illustration oh researchers look up at a blister pill pac. Part of the blister pack is filled with pills, while the center shows a sketch of a brain. -- biotech coverage from STAT — Mike Reddy for STAT

One by one, the companies behind Zoloft, Prozac, and Paxil soured on psychiatry.

It was the early 2000s, and as America warmed to the sounds of Sisqó and Shakira, the world’s largest pharmaceutical firms were running out of ideas to treat mental illness. Their blockbuster treatments for depression and schizophrenia had reshaped society and made billions of dollars in the process, but the old cash cows were soon to go generic. Efforts to one-up the last generation of drugs mostly resulted in incremental changes to aging medicines. And when insurance companies balked at paying brand-name prices for extended-release generics, the money dried up and the industry moved out.

“The mindset of Big Pharma in those days was one pill for millions and millions of people,” said John LaMattina, who led Pfizer’s research division from 1999 to 2007. “Everyone was looking for the next Lipitor, and when that fizzled out, there was an exodus out of psychotherapeutic areas.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Tori Bowie and the unacceptable rates of Black maternal death
Next article： After Sarepta trial failure, Duchenne families brace for more debate

hotspot

WSS

There’s no way to know how good AI health technologies are

In Gaza, a nonprofit 3D prints tourniquets and stethoscopes

Readout LOUD podcast: ESMO highlights & Roivant's big deal

Sarepta Duchenne therapy fails to meet primary endpoint in trial

Bernie Sanders bashes nonprofit hospitals over their tax breaks

Sarepta Duchenne therapy fails to meet primary endpoint in trial

explore

knowledge

knowledge

Alkermes shareholders re

DeepMind touts AlphaFold's new skills as protein folding AI models face off

How one medical school became remarkably diverse

Massive project maps cells in human brain in unprecedented detail

Anesthesiologist group: stop taking Ozempic before surgery

Kidney transplant patients stopped immunosuppressants in trial

Jerome Adams on the need for new antivirals for Covid

Readout LOUD podcast: Merger Mondays, Ozempic panic

Medical leaders decry Supreme Court decision on affirmative action

UnitedHealth’s Q3 profit jumps as medical costs rise more slowly

entertainment

How clinical AI models' predictive power can degrade over time

Humana CEO Bruce Broussard to step down in 2024

Cancer cells are shown to suck energy source from immune cells

Sarepta Duchenne therapy fails to meet primary endpoint in trial

Researchers CRISPR chickens in bid to protect them from bird flu

What is microchimerism and how does it affect maternal health?

knowledge

explore

hotspot

hotspot